Sanofi (SANp)
Euronext Paris • Healthcare
April 17, 2026 at 17:30 UTC
About Sanofi
Sanofi is a healthcare company that discovers, manufactures, and supplies medicines and vaccines used in clinical practice. Clinical programs target evidence that can be translated into labeling, and medical information supports safe use after approval. Plants operate to validated procedures, and logistics are planned so pharmacies, hospitals, and clinics receive steady supply. Regional teams handle access and pharmacovigilance under local rules while global functions maintain shared standards. Reporting sits inside the healthcare sector with a focus on operating facts rather than narrative goals. The company describes its role as maintaining continuity for health systems while adding new options through measured change. The stance is process first, with patient safety and data integrity kept at the center of decisions.
Analyst Ratings
Fundamentals & Financials
TTM is calculated as the sum of the four most recently completed quarters. This is a standard approach when monthly or real-time data is not available.
Income Statement
Balance Sheet
Financial Highlights
Dividends History
Split History
Earnings Calendar
Technical Indicators
Sanofi's Technical Indicators Summary
Banco Santander’s listing presents a neutral technical picture with short-term averages marginally supportive while longer-term EMAs sit above the market, producing mixed signals. Momentum and RSI are modestly positive and MACD lacks strong conviction, while ADX indicates a weak trend. Volatility is moderate and OBV shows no clear accumulation pattern, and the classic pivot lies above the current price, offering a level of resistance. Overall indicators are balanced between shallow buying and longer-term overhead averages. Technical takeaway: Neutral technical posture with short-term support offset by longer-term moving-average resistance.
| Indicator | Value |
|---|---|
RSI (14) | 61.53 |
Stochastic %K (14, 3, 3) | — |
CCI (20) | — |
WPR (14) | — |
Momentum (10) | -2.02 |
MFI | 42.29 |
MACD Level (12, 26) | 0.52 |
Bollinger Bands | — |
ATR (14) | $1.69 (2.09%) |
ADX (14) | 14.68 |
OBV | 6,066,981 |
Classic Pivot Point | $81.51 |
Fibonacci Pivot Point | $81.51 |
Simple Moving Averages | —(5 indicators) |
Exponential Moving Averages | $80.05 - $82.71(5 indicators) |
Get premium market insights delivered directly to your inbox.
Today's Snapshot
The day wrapped with SANp preserving a mild 1.36% upside gap, closing near 81.95. The day closed with SANp still facing an upcoming earnings catalyst in 6 days on 23 April. SANp edges higher ahead of an upcoming earnings catalyst, maintaining a mild upside bias.
Price Change
from €82.1 close
-€0.04
Trading Volume
Below avg (2.4M)
907.9K
vs S&P 500 Today
Moderate Underperformance
-0.20%
52-Week Position
Lower range
30.2%
Updated: April 17, 2026 at 15:04 UTC
Quote Summary
SANp Headlines
Japan clears Dupixent for bullous pemphigoid
March 24, 2026
Goldman’s Top Healthcare Picks Gain Fresh Catalysts
March 15, 2026
Azoria ETFs shut, Novartis India stake sold, tariff shock
February 20, 2026